{"entity":{"type":"insider","cik":"0001747677","url":"/insider/0001747677","json_url":"/insider/0001747677.json","name":"Cormorant Private Healthcare Fund II, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":15,"first":"2020-06-18","last":"2025-10-01","span_basis":"filed_date"},"name_variants":[{"name":"Cormorant Private Healthcare Fund II, LP","source":"filing","n_filings":15,"first_seen":"2020-06-18","last_seen":"2025-10-01"}],"transactions":[{"id":4192953,"accession":"0000929638-25-003712","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712#line-5","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5827.0,"shares_display":"5,827","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":40555.92,"total_display":"40,555.92","total_whole":"40,556","shares_owned_after":1994173.0,"shares_owned_after_display":"1,994,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4192948,"accession":"0000929638-25-003712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6494151.0,"shares_display":"6,494,151","price_per_share":7.210739045026825,"price_display":"7.21","price_state":"stated","total_value":46827628.18,"total_display":"46,827,628.18","total_whole":"46,827,628","shares_owned_after":4800000.0,"shares_owned_after_display":"4,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider","n_lines":4},{"id":8645506,"accession":"0000929638-23-002739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002739","line_url":"/filing/0000929638-23-002739#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58839.0,"shares_display":"58,839","price_per_share":59.8973,"price_display":"59.90","price_state":"stated","total_value":3524297.2347,"total_display":"3,524,297.23","total_whole":"3,524,297","shares_owned_after":8494151.0,"shares_owned_after_display":"8,494,151","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-10","scope":"insider"},{"id":8281367,"accession":"0000929638-23-002692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67814.0,"shares_display":"67,814","price_per_share":57.3188,"price_display":"57.32","price_state":"stated","total_value":3887017.1032,"total_display":"3,887,017.10","total_whole":"3,887,017","shares_owned_after":8435312.0,"shares_owned_after_display":"8,435,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-04","scope":"insider"},{"id":8281363,"accession":"0000929638-23-002692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150487.0,"shares_display":"150,487","price_per_share":57.252,"price_display":"57.25","price_state":"stated","total_value":8615681.724,"total_display":"8,615,681.72","total_whole":"8,615,682","shares_owned_after":8367498.0,"shares_owned_after_display":"8,367,498","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":8281358,"accession":"0000929638-23-002692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74911.0,"shares_display":"74,911","price_per_share":57.37,"price_display":"57.37","price_state":"stated","total_value":4297644.07,"total_display":"4,297,644.07","total_whole":"4,297,644","shares_owned_after":8217011.0,"shares_owned_after_display":"8,217,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":7856811,"accession":"0000929638-23-002058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002058","line_url":"/filing/0000929638-23-002058#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"GreenLight Biosciences Holdings, PBC","issuer_ticker":"GRNA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9188659.0,"shares_display":"9,188,659","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-24","scope":"insider"},{"id":9209844,"accession":"0000929638-22-001904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-22-001904","line_url":"/filing/0000929638-22-001904#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307692.0,"shares_display":"307,692","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":10813246.0,"shares_owned_after_display":"10,813,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-21","scope":"insider"},{"id":6144548,"accession":"0000929638-22-001901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-22-001901","line_url":"/filing/0000929638-22-001901#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307692.0,"shares_display":"307,692","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":10813246.0,"shares_owned_after_display":"10,813,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-20","scope":"insider"},{"id":4276853,"accession":"0001567619-21-013838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-013838","line_url":"/filing/0001567619-21-013838#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950000.0,"shares_display":"950,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":15200000.0,"total_display":"15,200,000.00","total_whole":"15,200,000","shares_owned_after":10505553.0,"shares_owned_after_display":"10,505,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-22","scope":"insider"},{"id":4562799,"accession":"0001567619-21-013070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-013070","line_url":"/filing/0001567619-21-013070#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Aerovate Therapeutics, Inc.","issuer_ticker":"AVTE","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Chen Bihua","owner_display_name":"Cormorant Private Healthcare Fund II, LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":2030691.0,"shares_owned_after_display":"2,030,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-07","scope":"insider"},{"id":5227502,"accession":"0001567619-21-012781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-012781","line_url":"/filing/0001567619-21-012781#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":11400000.0,"total_display":"11,400,000.00","total_whole":"11,400,000","shares_owned_after":3202200.0,"shares_owned_after_display":"3,202,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":4108202,"accession":"0001567619-21-008744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-008744","line_url":"/filing/0001567619-21-008744#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":7650000.0,"total_display":"7,650,000.00","total_whole":"7,650,000","shares_owned_after":2776657.0,"shares_owned_after_display":"2,776,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-29","scope":"insider"},{"id":5496795,"accession":"0001567619-21-007374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-007374","line_url":"/filing/0001567619-21-007374#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Chen Bihua; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":5114844.0,"shares_owned_after_display":"5,114,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":2164949,"accession":"0001567619-20-021488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-021488","line_url":"/filing/0001567619-20-021488#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":14400000.0,"total_display":"14,400,000.00","total_whole":"14,400,000","shares_owned_after":2292060.0,"shares_owned_after_display":"2,292,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":2116179,"accession":"0001567619-20-020222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-020222","line_url":"/filing/0001567619-20-020222#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":425000.0,"shares_display":"425,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":8075000.0,"total_display":"8,075,000.00","total_whole":"8,075,000","shares_owned_after":3270544.0,"shares_owned_after_display":"3,270,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-23","scope":"insider"},{"id":2129790,"accession":"0001567619-20-012814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-012814","line_url":"/filing/0001567619-20-012814#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Akouos, Inc.","issuer_ticker":"AKUS","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Private Healthcare Fund II, LP; Chen Bihua; Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP","owner_display_name":"Cormorant Private Healthcare Fund II, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":290000.0,"shares_display":"290,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4930000.0,"total_display":"4,930,000.00","total_whole":"4,930,000","shares_owned_after":789989.0,"shares_owned_after_display":"789,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-02","scope":"insider"},{"id":2672887,"accession":"0001567619-20-012364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-012364","line_url":"/filing/0001567619-20-012364#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400000.0,"total_display":"5,400,000.00","total_whole":"5,400,000","shares_owned_after":2514545.0,"shares_owned_after_display":"2,514,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001821586","name":"MoonLake Immunotherapeutics","url":"/issuer/0001821586","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2023-10-04","last_seen":"2025-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001822691","name":"GreenLight Biosciences Holdings, PBC","url":"/issuer/0001822691","role":"Other","n_filings":1,"first_seen":"2023-07-24","last_seen":"2023-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001761918","name":"Erasca, Inc.","url":"/issuer/0001761918","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2021-07-22","last_seen":"2022-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001798749","name":"Aerovate Therapeutics, Inc.","url":"/issuer/0001798749","role":"Other","n_filings":1,"first_seen":"2021-07-07","last_seen":"2021-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-30","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Therapeutics Inc.","url":"/issuer/0001724979","role":"Other","n_filings":1,"first_seen":"2021-04-29","last_seen":"2021-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Other","n_filings":1,"first_seen":"2021-04-01","last_seen":"2021-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001826892","name":"BioAtla, Inc.","url":"/issuer/0001826892","role":"Ten percent owner","n_filings":1,"first_seen":"2020-12-22","last_seen":"2020-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Ten percent owner","n_filings":1,"first_seen":"2020-11-23","last_seen":"2020-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001722271","name":"Akouos, Inc.","url":"/issuer/0001722271","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-02","last_seen":"2020-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Ten percent owner","n_filings":1,"first_seen":"2020-06-18","last_seen":"2020-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001747677","retrieved_at":"2026-08-22T13:58:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}